Awards for “FRESENIUS KABI, LLC”
25 awards on this page · sorted by amount · page 49
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2D326F3579 | FRESENIUS KABI, LLC | Department of Defense | $117.5 | 2026-01-09 | 2026-01-12 | 325411 | 4570485270!ROCURONIUM 50 MG/5 ML VIAL 5ML |
| SPE2D326F3578 | FRESENIUS KABI, LLC | Department of Defense | $117.5 | 2026-01-09 | 2026-01-12 | 325411 | 4570485267!ROCURONIUM 50 MG/5 ML VIAL 5ML |
| SPE2D326F3577 | FRESENIUS KABI, LLC | Department of Defense | $117.5 | 2026-01-09 | 2026-01-12 | 325411 | 4570485266!ROCURONIUM 50 MG/5 ML VIAL 5ML |
| SPE2D326F3575 | FRESENIUS KABI, LLC | Department of Defense | $117.5 | 2026-01-09 | 2026-01-12 | 325411 | 4570485265!ROCURONIUM 50 MG/5 ML VIAL 5ML |
| SPE2D326F3782 | FRESENIUS KABI, LLC | Department of Defense | $116.85 | 2026-01-13 | 2026-01-14 | 325411 | 4570507644!DIPHENHYDRAMINE 50 MG/ML VIALML |
| SPE2D325F458X | FRESENIUS KABI, LLC | Department of Defense | $116.85 | 2025-09-25 | 2025-09-26 | 325411 | 4569588923!DIPHENHYDRAMINE 50 MG/ML VIALML |
| SPE2D325F345S | FRESENIUS KABI, LLC | Department of Defense | $116.85 | 2025-08-26 | 2025-08-27 | 325411 | 4569226711!DIPHENHYDRAMINE 50 MG/ML VIALML |
| SPE2D321F219K | FRESENIUS KABI, LLC | Department of Defense | $116.44 | 2021-07-26 | 2021-07-29 | 325411 | 4554229226!XYLOCAINE 1%-EPI 1:100,000 20 ML VIAL 25 |
| SPE2D326F001Z | FRESENIUS KABI, LLC | Department of Defense | $115.4 | 2026-04-08 | 2026-04-09 | 325411 | 4571434075!DEXAMETHASONE 120 MG/30 ML VL 30ML |
| SPE2D326F0095 | FRESENIUS KABI, LLC | Department of Defense | $115.4 | 2025-10-02 | 2025-10-03 | 325411 | 4569678696!DEXAMETHASONE 120 MG/30 ML VL 30ML |
| SPE2D325F379B | FRESENIUS KABI, LLC | Department of Defense | $115.4 | 2025-09-03 | 2025-09-04 | 325411 | 4569322164!DEXAMETHASONE 120 MG/30 ML VL 30ML |
| SPE2D325F379A | FRESENIUS KABI, LLC | Department of Defense | $115.4 | 2025-09-03 | 2025-09-04 | 325411 | 4569322165!DEXAMETHASONE 120 MG/30 ML VL 30ML |
| SPE2D325F5315 | FRESENIUS KABI, LLC | Department of Defense | $114.56 | 2025-01-30 | 2025-02-04 | 325411 | 4567104183!DIPHENHYDRAMINE HYDROCHLORIDE INJ USP 50 |
| SPE2D324F7816 | FRESENIUS KABI, LLC | Department of Defense | $114.56 | 2024-04-03 | 2024-04-08 | 325411 | 4564159717!DIPHENHYDRAMINE HYDROCHLORIDE INJ USP 50 |
| SPE2D322F8836 | FRESENIUS KABI, LLC | Department of Defense | $113.6 | 2022-03-07 | 2022-03-10 | 325411 | 4556475085!GENTAMICIN SULFATE INJECTION USP 40MG EQ |
| SPE2D322F5187 | FRESENIUS KABI, LLC | Department of Defense | $113.6 | 2022-01-03 | 2022-01-06 | 325411 | 4555832736!GENTAMICIN SULFATE INJECTION USP 40MG EQ |
| SPE2D322F514Y | FRESENIUS KABI, LLC | Department of Defense | $113.6 | 2022-09-01 | 2022-09-06 | 325411 | 4558359063!GENTAMICIN SULFATE INJECTION USP 40MG EQ |
| SPE2D321F320W | FRESENIUS KABI, LLC | Department of Defense | $113.6 | 2021-09-15 | 2021-09-20 | 325411 | 4554806326!GENTAMICIN SULFATE INJECTION USP 40MG EQ |
| SPE2D321F1655 | FRESENIUS KABI, LLC | Department of Defense | $113.6 | 2020-11-04 | 2020-11-09 | 325411 | 4551634448!GENTAMICIN SULFATE INJECTION USP 40MG EQ |
| SPE2D324F092C | FRESENIUS KABI, LLC | Department of Defense | $113.07 | 2024-07-03 | 2024-07-09 | 325411 | 4565076971!LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE |
| SPE2D325F1358 | FRESENIUS KABI, LLC | Department of Defense | $109.32 | 2024-11-08 | 2024-11-14 | 325411 | 4566397161!XYLOCAINE 1% VIAL 20ML |
| SPE2D325F0590 | FRESENIUS KABI, LLC | Department of Defense | $109.32 | 2024-10-16 | 2024-10-21 | 325411 | 4566148164!XYLOCAINE 1% VIAL 20ML |
| SPE2D324F206S | FRESENIUS KABI, LLC | Department of Defense | $109.32 | 2024-08-19 | 2024-08-22 | 325411 | 4565515723!XYLOCAINE 1% VIAL 20ML |
| SPE2D322F377B | FRESENIUS KABI, LLC | Department of Defense | $109.2 | 2022-08-04 | 2022-08-05 | 325411 | 4558027931!ACETYLCYSTEINE 200 MG/ML (20%) SOLUTION |
| SPE2D322F144A | FRESENIUS KABI, LLC | Department of Defense | $109.2 | 2022-05-24 | 2022-05-27 | 325411 | 4557333046!ACETYLCYSTEINE 200 MG/ML (20%) SOLUTION |